Oral ganciclovir | Valganciclovir | p-value | |
---|---|---|---|
3 months (n = 37) | 3 months (n = 51) | ||
CAR scorea, median (quartiles) | |||
3 months | 2 (0 – 4) | 0 (0 – 2) | 0.02 |
12 months | 3 (2 – 6) | 1.5 (0 – 3) | 0.002 |
CAR score/TBBb, median (quartiles) | |||
3 months | 0.5 (0 - 1) | 0 (0 - 0.5) | 0.008 |
12 months | 0.43 (0.2-0.67) | 0.14 (0-0.5) | 0.001 |
At least one episode of AR grade ≥ 1, % (n) | |||
3 months | 68% (25/37) | 44% (20/45) | 0.03 |
12 months | 84% (31/37) | 62% (28/45) | 0.02 |
At least one episode of AR grade ≥ 2, % (n) | |||
3 months | 51% (19/37) | 29% (13/45) | 0.04 |
12 months | 73% (27/37) | 49% (22/45) | 0.03 |
At least two episodes of AR grade ≥ 2, % (n) | |||
3 months | 24% (9/37) | 13% (6/45) | n.s |
12 months | 41% (15/37) | 20% (9/45) | 0.04 |
Number of TBB, median (quartiles) | |||
3 months | 4 (3 – 4) | 4 (3 – 4) | n.s |
12 months | 9 (8 – 9) | 8 (6 – 8) | 0.001 |